Skip to main content

CervoMed Inc.

CRVO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001053691

No open-market purchases or sales by CervoMed Inc. insiders were filed in the last 90 days; 37 institutions reported holding it in 13F filings for Q2 2026, worth $5.42M in total; no superinvestor holds it.

13F holders, Q3 2024

Institutional positions in CervoMed Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
50
+13 vs. Q2 2024
Shares held
3.51M
+362.7K (+11.5%) vs. Q2 2024
Total value
$51.2M
−$2.62M (−4.9%) vs. Q2 2024
New holders
16
12 more added
Sold out
3
10 more reduced

1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q2 2024: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting CRVO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ3 2024: 50 institutions
Q1 2021: 0 institutionsQ2 2021: 0 institutionsQ3 2021: 0 institutionsQ4 2021: 0 institutionsQ1 2022: 0 institutionsQ2 2022: 15 institutionsQ3 2022: 12 institutionsQ4 2022: 13 institutionsQ1 2023: 12 institutionsQ2 2023: 11 institutionsQ3 2023: 12 institutionsQ4 2023: 12 institutionsQ1 2024: 20 institutionsQ2 2024: 38 institutionsQ3 2024: 50 institutionsQ4 2024: 49 institutionsQ1 2025: 48 institutionsQ2 2025: 45 institutionsQ3 2025: 45 institutionsQ4 2025: 48 institutionsQ1 2026: 36 institutionsQ2 2026: 37 institutions
Value heldQ3 2024: $51.2M
Q1 2021: $0Q2 2021: $0Q3 2021: $0Q4 2021: $0Q1 2022: $0Q2 2022: $1.39MQ3 2022: $1.00MQ4 2022: $923.7KQ1 2023: $838.9KQ2 2023: $589.9KQ3 2023: $1.68MQ4 2023: $2.48MQ1 2024: $58.6MQ2 2024: $59.0MQ3 2024: $51.2MQ4 2024: $3.46MQ1 2025: $20.9MQ2 2025: $13.7MQ3 2025: $17.3MQ4 2025: $17.4MQ1 2026: $6.97MQ2 2026: $5.42M
Institutions holding CRVO and their total value by quarter
QuarterHoldersValue
Q2 202637$5.42M
Q1 202636$6.97M
Q4 202548$17.4M
Q3 202545$17.3M
Q2 202545$13.7M
Q1 202548$20.9M
Q4 202449$3.46M
Q3 202450$51.2M
Q2 202438$59.0M
Q1 202420$58.6M
Q4 202312$2.48M
Q3 202312$1.68M
Q2 202311$589.9K
Q1 202312$838.9K
Q4 202213$923.7K
Q3 202212$1.00M
Q2 202215$1.39M
Q1 20220$0
Q4 20210$0
Q3 20210$0
Q2 20210$0
Q1 20210$0

Institutions, Q3 2024

Shares, value and share of portfolio for each institution holding CervoMed Inc.; share changes are against Q2 2024.

Institutions holding CRVO in Q3 2024
InstitutionSharesValue% of portfolioChange in sharesAction
Ra Capital Management, L.P.817,120$11.9M0.14%00.0%Unchanged
AWM Investment Company, Inc.449,006$6.56M0.79%+134,966+43.0%Added
Armistice Capital, LLC402,000$5.87M0.15%−238,000−37.2%Reduced
Vanguard Group Inc400,299$5.84M0.00%−8,476−2.1%Reduced
BlackRock, Inc.318,766$4.65M0.00%+318,766New
Ikarian Capital, LLC202,345$2.95M0.92%−35,000−14.7%Reduced
Soleus Capital Management, L.P.126,614$1.85M0.15%00.0%Unchanged
Geode Capital Management, LLC114,934$1.68M0.00%+14,042+13.9%Added
State Street Corp104,456$1.53M0.00%+22,903+28.1%Added
Crown Advisors Management, Inc.100,000$1.46M0.94%00.0%Unchanged
CWM, LLC59,120$863.0K0.00%+32+0.1%Added
Boothbay Fund Management, LLC58,837$859.0K0.03%−10,177−14.7%Reduced
Northern Trust Corp53,692$783.9K0.00%+53,692New
Renaissance Technologies LLC47,933$699.8K0.00%+15,600+48.2%Added
Morgan Stanley45,103$658.5K0.00%+37,436+488.3%Added
Citizens Financial Group Inc30,509$445.4K0.01%+3,553+13.2%Added
Adage Capital Partners GP, L.L.C.28,600$417.6K0.00%−11,433−28.6%Reduced
Nuveen Asset Management, LLC19,465$284.2K0.00%+19,465New
J. Goldman & Co LP16,707$243.9K0.01%00.0%Unchanged
Millennium Management LLC15,569$227.3K0.00%+15,569New
Charles Schwab Investment Management Inc12,722$185.7K0.00%00.0%Unchanged
Citadel Advisors LLC12,493$182.4K0.00%+12,493New
Sherbrooke Park Advisers LLC11,766$171.8K0.04%+11,766New
Marshall Wace, LLP11,657$170.2K0.00%+11,657New
Barclays PLC7,748$113.1K0.00%+5,919+323.6%Added
Rhumbline Advisers4,552$66.5K0.00%−1,075−19.1%Reduced
JPMorgan Chase & Co4,112$60.0K0.00%+1,810+78.6%Added
Citigroup Inc3,896$56.9K0.00%+2,721+231.6%Added
Bank of America Corp3,886$56.7K0.00%−2,483−39.0%Reduced
FMR LLC3,863$56.4K0.00%+3,863New
Mirae Asset Global ETFs Holdings Ltd.3,006$43.9K0.00%+3,006New
Corebridge Financial, Inc.2,888$42.2K0.00%−17−0.6%Reduced
UBS Group AG2,537$37.0K0.00%+903+55.3%Added
Legal & General Group Plc2,114$30.9K0.00%00.0%Unchanged
Wells Fargo & Company1,664$24.3K0.00%−66−3.8%Reduced
Hoey Investments, Inc1,080$18.5K0.00%00.0%Unchanged
Russell Investments Group, Ltd.1,195$17.4K0.00%+1,195New
Royal Bank of Canada766$11.0K0.00%+255+49.9%Added
Tower Research Capital LLC (TRC)557$8.13K0.00%+557New
Ameritas Investment Partners, Inc.529$7.72K0.00%00.0%Unchanged
New York State Common Retirement Fund400$5.84K0.00%−5,500−93.2%Reduced
Advisor Group Holdings, Inc.395$5.77K0.00%00.0%Unchanged
California State Teachers Retirement System391$5.71K0.00%00.0%Unchanged
Amalgamated Bank187$3.00K0.00%00.0%Unchanged
DT Investment Partners, LLC142$2.07K0.00%+142New
Harbour Investments, Inc.66$9640.00%00.0%Unchanged
Sterling Capital Management LLC6$880.00%+6New
Nelson, Van Denburg & Campbell Wealth Management Group, LLC2$290.00%+2New
Danske Bank A/S1$150.00%+1New
Capital Advisors, Ltd. LLC33$00.00%+33New
Bank of New York Mellon Corp0$00.00%−13,784−100.0%Sold out
Fred Alger Management, LLC0$00.00%−3,500−100.0%Sold out
Manchester Capital Management LLC0$00.00%−138−100.0%Sold out
BlackRock Inc.––––Not filed